Literature DB >> 15028355

The case for an adverse interaction between aspirin and non-steroidal anti-inflammatory drugs: is it time to believe the hype?

Jeptha P Curtis, Harlan M Krumholz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15028355     DOI： 10.1016/j.jacc.2004.01.001

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

Review 1.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 2.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

3.  Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.

Authors:  M E Farkouh; J D Greenberg; R V Jeger; K Ramanathan; F W A Verheugt; J H Chesebro; H Kirshner; J S Hochman; C L Lay; S Ruland; B Mellein; P T Matchaba; V Fuster; S B Abramson
Journal:  Ann Rheum Dis       Date:  2007-04-05       Impact factor: 19.103

4.  In Silico Prediction of Interactions between Site II on Human Serum Albumin and Profen Drugs.

Authors:  Hideto Isogai; Noriaki Hirayama
Journal:  ISRN Pharm       Date:  2013-03-06

5.  In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1.

Authors:  Alexey Goltsov; Galina Lebedeva; Ian Humphery-Smith; Gregory Goltsov; Oleg Demin; Igor Goryanin
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.